Aim: We aimed to evaluate the feasibility and efficiency of a guidelines-compliant NAFLD assessment algorithm in patients with newly diagnosed type 2 diabetes (T2D). Methods: Consecutive patients aged < 75 newly diagnosed with T2D without coexisting liver disease or excessive alcohol consumption were enrolled. Patients were stratified based on liver enzymes, fatty liver index, ultrasound, fibrosis scores and liver stiffness measurement. Referral rates and positive predictive values (PPVs) for histological non-alcoholic steatohepatitis (NASH) and significant fibrosis were evaluated. Results: Of the 171 enrolled patients (age 59 ± 10.2 years, 42.1% females), 115 (67.3%) were referred to a hepatologist due to abnormal liver enzymes (n = 60) or steatosis plus indeterminate (n = 37) or high NAFLD fibrosis score (n = 18). Liver biopsy was proposed to 30 patients (17.5%), but only 14 accepted, resulting in 12 NASH, one with significant fibrosis. The PPV of hepatological referral was 12/76 (15.8%) for NASH and 1/76 (1.3%) for NASH with significant fibrosis. The PPV of liver biopsy referral was 12/14 (85.7%) for NASH and 1/14 (7.1%) for NASH with significant fibrosis. Conclusions: By applying a guidelines-compliant algorithm, many patients with T2D were referred for hepatological assessment and liver biopsy. Further studies are necessary to refine non-invasive algorithms.

Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study / Besutti, G.; Bonilauri, L.; Manicardi, E.; Venturelli, F.; Bonelli, E.; Monelli, F.; Manicardi, V.; Valenti, L.; Ligabue, G.; Schianchi, S.; Massari, M.; Riva, N.; Froio, E.; Tagliavini, E.; Pattacini, P.; Giorgi Rossi, P.. - In: DIABETES RESEARCH AND CLINICAL PRACTICE. - ISSN 0168-8227. - 177:(2021), pp. 108882-108882. [10.1016/j.diabres.2021.108882]

Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study

Besutti G.;Bonilauri L.;Manicardi E.;Venturelli F.;Monelli F.;Ligabue G.;Massari M.;Riva N.;Tagliavini E.;
2021

Abstract

Aim: We aimed to evaluate the feasibility and efficiency of a guidelines-compliant NAFLD assessment algorithm in patients with newly diagnosed type 2 diabetes (T2D). Methods: Consecutive patients aged < 75 newly diagnosed with T2D without coexisting liver disease or excessive alcohol consumption were enrolled. Patients were stratified based on liver enzymes, fatty liver index, ultrasound, fibrosis scores and liver stiffness measurement. Referral rates and positive predictive values (PPVs) for histological non-alcoholic steatohepatitis (NASH) and significant fibrosis were evaluated. Results: Of the 171 enrolled patients (age 59 ± 10.2 years, 42.1% females), 115 (67.3%) were referred to a hepatologist due to abnormal liver enzymes (n = 60) or steatosis plus indeterminate (n = 37) or high NAFLD fibrosis score (n = 18). Liver biopsy was proposed to 30 patients (17.5%), but only 14 accepted, resulting in 12 NASH, one with significant fibrosis. The PPV of hepatological referral was 12/76 (15.8%) for NASH and 1/76 (1.3%) for NASH with significant fibrosis. The PPV of liver biopsy referral was 12/14 (85.7%) for NASH and 1/14 (7.1%) for NASH with significant fibrosis. Conclusions: By applying a guidelines-compliant algorithm, many patients with T2D were referred for hepatological assessment and liver biopsy. Further studies are necessary to refine non-invasive algorithms.
2021
177
108882
108882
Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study / Besutti, G.; Bonilauri, L.; Manicardi, E.; Venturelli, F.; Bonelli, E.; Monelli, F.; Manicardi, V.; Valenti, L.; Ligabue, G.; Schianchi, S.; Massari, M.; Riva, N.; Froio, E.; Tagliavini, E.; Pattacini, P.; Giorgi Rossi, P.. - In: DIABETES RESEARCH AND CLINICAL PRACTICE. - ISSN 0168-8227. - 177:(2021), pp. 108882-108882. [10.1016/j.diabres.2021.108882]
Besutti, G.; Bonilauri, L.; Manicardi, E.; Venturelli, F.; Bonelli, E.; Monelli, F.; Manicardi, V.; Valenti, L.; Ligabue, G.; Schianchi, S.; Massari, M.; Riva, N.; Froio, E.; Tagliavini, E.; Pattacini, P.; Giorgi Rossi, P.
File in questo prodotto:
File Dimensione Formato  
Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes A prospective study..pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 1.6 MB
Formato Adobe PDF
1.6 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1252265
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 1
social impact